Kal Patel

CEO & Co-Founder, @BrightInsightco | Senior Advisor in Digital Health, @BCG

[BrightInsight @Brightinsightco]

We are excited to announce that BrightInsight has been named to Forbes prestigious ranking of America’s Best Startup Employers for 2024 for the second year in a row! 🏆 https://t.co/F7T8v5WTr0

[BrightInsight @Brightinsightco]

In this interview, @JamieJay2 spoke with @Butlerjustin, Partner at @EclipseVentures, about the firm’s investment thesis when it comes to GenAI, the potential of GenAI & digital to improve patient-provider communication, and how AI- powered technologies will enable data sharing.

[BrightInsight @Brightinsightco]

Adoption and scaling of #digitalhealth remains a significant challenge for life science companies. Explore how you can make your digital solutions stand out in our new white paper, Go-to-Market Strategies for Patient-Facing Digital Health Solutions: https://t.co/ZvpQ8iI5Oz

[BrightInsight @Brightinsightco]

This recognition was fueled by BrightInsight’s multiple global app launches, product and platform enhancements and new partnerships in 2023, all of which contributed to our 431% revenue growth. https://t.co/qCD0K4mxcs

[BrightInsight @Brightinsightco]

We are proud to share that BrightInsight was awarded 307th place in the Deloitte Technology #Fast500, a ranking of the 500 fastest-growing technology, media, telecommunications, life sciences, fintech, and energy tech companies in North America! 🏆

[BrightInsight @Brightinsightco]

But #pharma would do well to trade its FOMU for FOMO—fear of missing out—because #digitalhealth technologies can unlock huge amounts of value while addressing critical adoption and adherence issues. @_KalPatel @Forbes https://t.co/1aQLDXxCNj

[BrightInsight @Brightinsightco]

When it comes to #digitalhealth, the pharmaceutical industry seems to be stricken with FOMU—fear of messing up. It’s not without reason. After all, patients’ lives are on the line, and pharma executives face a host of other high-pressure risks. @_KalPatel @Forbes

[BrightInsight @Brightinsightco]

What an exciting Q2 for #BrightInsight! 🤩🚀 Some highlights includes earning the @Frost_Sullivan IoT Healthcare Solutions 2023 Global Company of the Year Award, receiving the CE mark and more. Here’s a video recap of our Q2 highlights! 🌟

https://t.co/7i1ZEQu1rG

[Kal Patel @_KalPatel]

This year is shaping up to be an inflection point for #digitalhealth. Many investors expect digital health dollars in 2023 to return to 2020 levels. I’ve been reflecting on my 10 years in the industry. Here are some learnings from what worked and didn’t. https://t.co/vXENaPFAc3

[BrightInsight @Brightinsightco]

Our own @_KalPatel is joined by Brad Gescheider from @sanofi Wainwright Fishburn from @CooleyLLP and @jameslu20 from @my_helix to discuss partnering strategies for success in digital health 🤩 #BIO2022

[Jamie Eisinger Burgess @JamieJay2]

“Software as a Medical Device “SaMD” will be foundational to generating value around therapies and devices, and it’s at the heart of what we do @Brightinsightco ” - @_KalPatel shares during #BIO2022

[BrightInsight @Brightinsightco]

.@paularthurupham of @roche/@genentech talks about measuring ROI of #SaMD by thinking about the “Return to Patient” and the benefits you’re delivering to patients. #DTxWest

[BrightInsight @Brightinsightco]

Dave Matthews (@e2pi) kicks off our #DTxWest panel and shares recent stat: “100% of #digitalhealth leaders agree that #SaMD initiatives take longer and cost more than originally believed.”

[BrightInsight @Brightinsightco]

Attending #DTxWest? Be sure to catch the Discussion Panel: Minding the Gap: How to align expectations and realities when building Software as a Medical Device at 3:40PM PST today!

[Jamie Eisinger Burgess @JamieJay2]

What is the greatest barrier to #digitalhealth adoption? Clinicians. It takes 17 years to change the practice of medicine. That’s 17 years after data and evidence exists around new best practices. 🤯 @chriswasden #dtxeast

[BrightInsight @Brightinsightco]

“In the early days of Pharma, we didn’t have device groups- it was an afterthought. Now that would be preposterous. Digital will be the same, becoming an integrated part of the drug lifecycle development from patient identification to dosing to adherence.” - @_KalPatel #DTxEast

[Kal Patel @_KalPatel]

Excited to be at #DTxEast today! I will be moderating the panel: Understanding the End-to-End Process of Building a Regulated Software as a Medical Device (SaMD) today at 12:50 EST. Come join us for an insightful discussion around the end-to-end process of SaMD. #brightinsight

[BrightInsight @Brightinsightco]

Attending #DTxEast? Stop by our booth to meet with the #BrightInsight team! We also have a virtual booth for all those attending virtually.

[Arif Nathoo @ArifNathooMD]

Enjoyed tonight's #HLTHAfterHours conversation with @toyinajayidoc, @_KalPatel, @adam_seabrook, Ryan Gillooly, and @jody_tropeano. Thank you for having me! https://t.co/3CssuRioj0

[BrightInsight @Brightinsightco]

Today BrightInsight announced our $101M Series C funding led by @gcvp! This funding will enable #BrightInsight to continue our hypergrowth, and to support the development and launch of game-changing #digitalhealth solutions for our customers. https://t.co/U03dfqRuW8